Skip to content

Metabolic Screening in Patients With Donnai-Barrow Syndrome

Metabolic Screening in Patients With Donnai-Barrow Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01509287
Enrollment
78
Registered
2012-01-12
Start date
2010-03-31
Completion date
2022-06-30
Last updated
2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Donnai-Barrow Syndrome

Keywords

Donnai-Barrow Syndrome (DBS), metabolic testing, genes, genetic

Brief summary

This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).

Detailed description

The purpose of this study is to better understand the role of certain nutrients and vitamins in promoting the healthy development of individuals with Donnai-Barrow Syndrome. The investigators hope that the information gained by studying the metabolism of children with Donnai-Barrow Syndrome and their family members will lead to significant advances in the treatment of this disease.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

All individuals affected with Donnai-Barrow Syndrome

Design outcomes

Primary

MeasureTime frame
measures of blood sugar, cholesterol, vitamins A and D, and other compounds5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026